38 results
8-K
EX-10.1
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option
424B5
NEXI
Neximmune Inc
5 Feb 24
Prospectus supplement for primary offering
4:34pm
or likelihood of the accomplishment of various scientific, clinical, regulatory and other product development objectives;
the pricing and reimbursement … , regulatory and other product development objectives;
the pricing and reimbursement of our product candidates, if approved;
the rate and degree
424B5
uaqjnzgmhbawm h6i
17 Jun 22
Prospectus supplement for primary offering
4:49pm
DEF 14A
6ut83v ivop8
3 May 22
Definitive proxy
4:16pm
S-3
owu9ly7x
9 Mar 22
Shelf registration
5:14pm
S-3
EX-4.5
b4ryw
9 Mar 22
Shelf registration
5:14pm
S-3
EX-4.6
txtuusq2n4f6j
9 Mar 22
Shelf registration
5:14pm